DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Sarich TC, Teng R, Peters GR. et al.
No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.
Clin Pharmacokinet 2003;
42: 485-492.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.